Koen van Besien, MD, PhD
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center · University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center · Weill Medical College of Cornell University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Koen van Besien, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:49 UTC. Open this list on ClinicalTrials.gov
- Early Ph1NCT05013437 · Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple MyelomaKoen van Besien · withdrawn · Multiple Myeloma · principal investigator
- Ph1NCT03143985 · Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple MyelomaKoen van Besien · completed · Multiple Myeloma · principal investigator
- Ph2NCT01745913 · Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic MalignanciesWeill Medical College of Cornell University · terminated · Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.